Logo

Spotfire, PPGx Partner For Pharmacogenomics

Jun 07, 2000
Premium

CAMBRIDGE, Mass.--Spotfire and PPGx have become partners to integrate PPGx’s pharmaco-genomics data warehouse and information mining product, GeneTrials, with Spotfire’s decision analytics portal, Spotfire.net. The companies said this will allow scientists to export large amounts of pharmacogenomics data into the Spotfire.net environment where they can visualize, analyze, share, and make informed decisions about the data.

Filed under

Informatics
Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.